Top Penny Stocks to Invest in 2026: High Potential Picks

best pennystocks 2026

Sources

Answer

Best Penny Stocks to Watch in 2026

Here is a curated list of penny stocks showing potential for 2026, based on recent market analysis, hedge fund interest, and sector trends. These picks are for informational purposes only and require your own due diligence given the high-risk nature of penny stocks.


1) Geron Corporation (NASDAQ: GERN)

  • Upside Potential: ~192%
  • Price: Around $1.43
  • Hedge Fund Holders: 37
  • Sector: Biotechnology, focused on cancer therapeutics
  • Catalysts:
    • Promising clinical trial data expected
    • Strong institutional backing
  • Risks:
    • Biotech clinical trial failures are common
    • High R&D expenses and cash burn

2) Taysha Gene Therapies Inc. (NASDAQ: TSHA)

  • Upside Potential: ~126%
  • Price: Around $4.86
  • Hedge Fund Holders: 32
  • Sector: Gene therapy development
  • Catalysts:
    • Multiple pipeline candidates approaching data readouts
    • Growing partnerships and collaborations
  • Risks:
    • Regulatory hurdles and competition
    • Volatility tied to clinical trial news

3) Atai Beckley N.V. (NASDAQ: ATAI)

  • Upside Potential: ~231%
  • Price: Around $3.76
  • Hedge Fund Holders: 21
  • Sector: Psychedelic mental health therapies
  • Catalysts:
    • Expanding pipeline in mental health treatments
    • Increasing investor interest in psychedelic sector
  • Risks:
    • Regulatory uncertainty
    • Early-stage company with execution risk

4) Invivyd, Inc. (NASDAQ: IVVD)

  • Upside Potential: ~298%
  • Price: Around $2.45
  • Hedge Fund Holders: 20
  • Sector: Bio-pharmaceuticals focusing on immune-oncology
  • Catalysts:
    • Upcoming clinical trial milestones
    • Potential partnership deals
  • Risks:
    • Clinical development risks
    • Competitive biotech landscape

5) ImmunityBio, Inc. (NASDAQ: IBRX)

  • Upside Potential: ~227%
  • Price: Around $2.59
  • Hedge Fund Holders: 18
  • Sector: Immunotherapy and vaccine development
  • Catalysts:
    • Pipeline progress in cancer vaccines
    • Strategic collaborations
  • Risks:
    • Market sensitivity to trial outcomes
    • Funding and dilution risk

6) Angel Studios Inc. (NYSE: ANGX)

  • Upside Potential: ~149%
  • Price: Around $4.31
  • Hedge Fund Holders: 5
  • Sector: Media and entertainment streaming
  • Catalysts:
    • Rapid audience and subscriber growth
    • Content expansion plans
  • Risks:
    • Market competition in streaming
    • Revenue model execution

7) American Bitcoin Corp (NASDAQ: ABTC)

  • Upside Potential: ~109%
  • Price: Around $1.82
  • Hedge Fund Holders: 5
  • Sector: Cryptocurrency mining and treasury management
  • Catalysts:
    • Growing Bitcoin holdings
    • Bitcoin price trends
  • Risks:
    • Crypto market volatility
    • Regulatory risks around digital assets

Summary Table

Ticker Company Sector Key Catalyst Key Risk Source
GERN Geron Corporation Biotechnology Promising clinical trials Trial failure risk Insider Monkey, Nasdaq
TSHA Taysha Gene Therapies Gene Therapy Pipeline milestones Regulatory hurdles Insider Monkey, Nasdaq
ATAI Atai Beckley N.V. Psychedelic Therapies Mental health pipeline growth Regulatory and execution risk Insider Monkey, Nasdaq
IVVD Invivyd, Inc. Immune-Oncology Trial milestones Clinical risks Insider Monkey, Nasdaq
IBRX ImmunityBio, Inc. Immunotherapy Vaccine pipeline progress Funding and trial risks Insider Monkey, Nasdaq
ANGX Angel Studios Inc. Media Streaming Audience growth Streaming competition Insider Monkey, Nasdaq
ABTC American Bitcoin Corp Cryptocurrency Mining Bitcoin treasury expansion Crypto volatility & regulation Insider Monkey, Nasdaq

Important Notes on Penny Stocks in 2026

  • Penny stocks carry high volatility and risk, including potential fraud and illiquidity.
  • Favor companies with clear catalysts, strong fundamentals, and institutional backing.
  • Focus on sectors with growth tailwinds in 2026 like biotech, AI-adjacent tech, renewable energy, and digital assets.
  • Diversification and disciplined risk management are essential.
  • Always verify current filings, news, and market data before trading.

Sponsored note: Any mention of CEA Industries Inc. (Nasdaq: BNC) is a paid advertisement on behalf of Creative Direct Marketing Group, Inc. (CDMG), engaged by the company. Disclosures: https://pennystocks.com/pages/disclaimer

Home

Discover

Library